Sign in
4

Changes in Ownership

Monopar Therapeutics Filed Acc 0001437749-25-021994

Chief Executive Officer gave up 5,865 shares (to pay taxes)

  • Chief Executive Officer acquired 13,344 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Robinson Chandler Chief Executive Officer 2025-06-30 Option exercise +13,344 79,337 D: show line 1 in the form
Robinson Chandler Chief Executive Officer 2025-06-30 Shares withheld for taxes −5,865 $35.78 $209,850 73,472 D: show line 2 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Robinson Chandler Chief Executive Officer 2025-06-30 Option exercise · Restricted Stock Units −13,344 81,325 D: show line 3 in the form
Loading xslF345X05/rdgdoc.xml…